Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DNMDP is a phosphodiesterase 3A inhibitor with clear cell-selective cytotoxicity. DNMDP binding to PDE3A promotes interaction between PDE3A and Schlafen 12.
Description | DNMDP is a phosphodiesterase 3A inhibitor with clear cell-selective cytotoxicity. DNMDP binding to PDE3A promotes interaction between PDE3A and Schlafen 12. |
In vitro | DNMDP (0-1000 μM; 48 hours) displays clear cell-selective cytotoxicity. HeLa cells undergo apoptosis upon DNMDP treatment, indicates by caspase activity detected by a caspase-sensitive luciferase assay and by PARP cleavage. DNMDP (100 nM) specifically inhibits both PDE3A and PDE3B, but it weakly inhibits PDE10. It also had little or no detectable effect on other phosphodiesterases. |
Molecular Weight | 304.34 |
Formula | C15H20N4O3 |
CAS No. | 328104-79-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DNMDP 328104-79-6 Others inhibitor inhibit